Orient Pharma Co., Ltd. (TPEX:4166)

Taiwan · Delayed Price · Currency is TWD

24.35

+0.15 (0.62%)

Mar 5, 2026, 1:30 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Overseas Business Division	59.92M	39.02M	63.07M	45.91M	10.45M
Overseas Business Division Growth	53.57%	-38.14%	37.37%	339.39%	21.20%
Plant Operating Department	1.16B	847.11M	446.27M	416.30M	400.42M
Plant Operating Department Growth	37.28%	89.82%	7.20%	3.97%	16.43%
Pharmaceutical Operations	-	3.78M	2.52M	1.13M	1.14M
Pharmaceutical Operations Growth	-	50.24%	122.83%	-0.88%	14.57%
Total	1.22B	889.91M	511.86M	463.34M	412.01M
Total Growth	37.41%	73.86%	10.47%	12.46%	16.54%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Taiwan	826.45M	679.80M	253.78M	323.43M	412.01M
Taiwan Growth	21.57%	167.88%	-21.54%	-21.50%	16.54%
United States	325.38M	178.49M	216.26M	108.62M	-
United States Growth	82.30%	-17.46%	99.09%	-	-
Philippines	13.25M	23.81M	-	-	-
Philippines Growth	-44.34%	-	-	-	-
China	34.43M	18.00K	37.92M	17.14M	-
China Growth	191155.56%	-99.95%	121.16%	-	-
Others	23.31M	7.80M	3.91M	14.15M	-
Others Growth	199.00%	99.23%	-72.34%	-	-
Total	1.22B	889.91M	511.86M	463.34M	412.01M
Total Growth	37.41%	73.86%	10.47%	12.46%	16.54%

Source: S&P Global Market Intelligence.